Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S F Shariat

Showing results (21-30 of 94) with videos related to

Pageof 10
Sort By:
Der Urologe. Ausg. A|March 19, 2013
[Use of PubMed to improve evidence-based medicine in routine urological practice]M Rink, L A Kluth, S F Shariat, et al.
Urology|December 18, 2001
Plasma levels of interleukin-6 and its soluble receptor are associated with prostate cancer progression and metastasisS F Shariat, B Andrews, M W Kattan, et al.
Der Urologe. Ausg. A|May 28, 2013
[The likelihood ratio: estimation of the impact of a diagnostic test on treatment decision]L A Kluth, M Rink, F K H Chun, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|August 11, 2014
Radical nephroureterectomy versus endoscopic procedures for the treatment of localised upper tract urothelial carcinoma: a meta-analysis and a systematic review of current evidence from comparative studiesR Yakoubi, P Colin, T Seisen, et al.
Der Urologe. Ausg. A|January 28, 2012
[Advanced bladder cancer in elderly patients. Prognostic outcomes and therapeutic strategies]M Rink, F K Chun, T F Chromecki, et al.
British Journal of Cancer|August 14, 2014
Pretherapeutic gamma-glutamyltransferase is an independent prognostic factor for patients with renal cell carcinomaS L Hofbauer, K I Stangl, M de Martino, et al.
Urology|November 9, 2000
Prognostic value of P53 nuclear accumulation and histopathologic features in T1 transitional cell carcinoma of the urinary bladderS F Shariat, A Z Weizer, A Green, et al.
Minerva Urologica E Nefrologica = the Italian Journal of Urology and Nephrology|January 22, 2015
Management of advanced bladder cancer in the era of targeted therapiesA Soave, O Engel, G Von Amsberg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 22, 2001
Prediction of response to salvage radiation therapy in patients with prostate cancer recurrence after radical prostatectomyA K Leventis, S F Shariat, M W Kattan, et al.
Urology|August 30, 2000
Correlation of preoperative plasma IGF-I levels with pathologic parameters and progression in patients undergoing radical prostatectomyS F Shariat, F Bergamaschi, H L Adler, et al.
Pageof 10

Showing results (21-30 of 94) with videos related to

Sort By:
Pageof 10
Der Urologe. Ausg. A|March 19, 2013
[Use of PubMed to improve evidence-based medicine in routine urological practice]M Rink, L A Kluth, S F Shariat, et al.
Urology|December 18, 2001
Plasma levels of interleukin-6 and its soluble receptor are associated with prostate cancer progression and metastasisS F Shariat, B Andrews, M W Kattan, et al.
Der Urologe. Ausg. A|May 28, 2013
[The likelihood ratio: estimation of the impact of a diagnostic test on treatment decision]L A Kluth, M Rink, F K H Chun, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|August 11, 2014
Radical nephroureterectomy versus endoscopic procedures for the treatment of localised upper tract urothelial carcinoma: a meta-analysis and a systematic review of current evidence from comparative studiesR Yakoubi, P Colin, T Seisen, et al.
Der Urologe. Ausg. A|January 28, 2012
[Advanced bladder cancer in elderly patients. Prognostic outcomes and therapeutic strategies]M Rink, F K Chun, T F Chromecki, et al.
British Journal of Cancer|August 14, 2014
Pretherapeutic gamma-glutamyltransferase is an independent prognostic factor for patients with renal cell carcinomaS L Hofbauer, K I Stangl, M de Martino, et al.
Urology|November 9, 2000
Prognostic value of P53 nuclear accumulation and histopathologic features in T1 transitional cell carcinoma of the urinary bladderS F Shariat, A Z Weizer, A Green, et al.
Minerva Urologica E Nefrologica = the Italian Journal of Urology and Nephrology|January 22, 2015
Management of advanced bladder cancer in the era of targeted therapiesA Soave, O Engel, G Von Amsberg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 22, 2001
Prediction of response to salvage radiation therapy in patients with prostate cancer recurrence after radical prostatectomyA K Leventis, S F Shariat, M W Kattan, et al.
Urology|August 30, 2000
Correlation of preoperative plasma IGF-I levels with pathologic parameters and progression in patients undergoing radical prostatectomyS F Shariat, F Bergamaschi, H L Adler, et al.
Pageof 10